Axinn partner Chad Landmon moderated a panel at the FDLI Annual Conference. "Ploy or Policy Tool - A Look at the Citizen Petition Process" addressed the risks and rewards of using the petition process as a tool for market success, and potential changes to the process as a result of the recent draft FDA guidance. Attendees learned about the multifaceted approach to deciding how and why to file a citizen petition and the pros and cons of doing so.
Ploy or Policy Tool: A Look at the Citizen Petition Process
May 6, 2016